AbbVie (ABBV) P/B ratio

P/B ratio · fiscal 2024
94.8×

The P/B ratio of AbbVie (ABBV) was 94.8× at the end of fiscal 2024 (December 31, 2024). That is 257.3% higher than the 26.5× of fiscal 2023. Figures as of 18 Nov 2026, 07:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio, fiscal 2024
94.8×
Change on fiscal 2023
+257.3%
Highest on record
94.8×fiscal 2024
Lowest on record
13.7×fiscal 2020
Fiscal years on record
102013–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

AbbVie P/B ratio, in more detail

Across the 10 fiscal year-ends on record (2013–2024), the highest was 94.8× in fiscal 2024 and the lowest 13.7× in fiscal 2020.

History · 10 fiscal years

P/B ratio at each fiscal year-end

AbbVie P/B ratio, year by year

AbbVie (ABBV) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
2025——$228.49-$1.84
202494.8× 257.3% up$177.70$1.88
202326.5× 59.3% up$154.97$5.84
202216.7× 6.6% up$161.61$9.70
202115.6× 13.9% up$135.40$8.67
202013.7×—$107.15$7.82
2019——$88.54-$5.51
2018——$92.19-$5.46
201730.4× 38.1% up$96.71$3.18
201622.0× 10.4% down$62.62$2.84
201524.6× 59.4% down$59.24$2.41
201460.5× 220.7% up$65.44$1.08
201318.9×—$52.81$2.80
2012———-$0.22

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of AbbVie and comparable companies
CompanyP/B ratio
Eli Lilly LLY47.5×
Johnson & Johnson JNJ8.2×
Merck & Co MRK6.7×
UnitedHealth Group UNH3.7×
Novartis NVS6.5×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on ABBV

AbbVie, figure by figure

AbbVie (ABBV) overview: price, valuation and scorecardAll health care companies by market value

AbbVie P/B ratio: questions and answers

What is AbbVie's P/B ratio?

The P/B ratio of AbbVie (ABBV) was 94.8× at the end of fiscal 2024 (December 31, 2024). That is 257.3% higher than the 26.5× of fiscal 2023.

What are the highest and lowest P/B ratio figures on record for AbbVie?

Across the 10 fiscal year-ends on record (2013–2024), the highest was 94.8× in fiscal 2024 and the lowest 13.7× in fiscal 2020.

How is AbbVie's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AbbVie (ABBV) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ABBV/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.